Testimony on PBM Disclosure

This document is about testimony presented to the ERISA Advisory Council by the Pharmaceutical Care Management Association (PCMA) on whether mandatory disclosure requirements should be imposed on pharmacy benefit managers (PBMs) pursuant to section 408(b)(2) of ERISA. The testimony argues that such mandatory disclosure rules are unnecessary, unprecedented, and counterproductive for PBM clients.